Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes Mellitus After New Onset of ST-Segment Elevation Myocardial Infarction (STEMI) (DISTEMI Study)

NCT05046483 is registered in ClinicalTrials.gov with German Diabetes Center as lead sponsor.

NCT NCT05046483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05046483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes Mellitus After New Onset of ST-Segment Elevation Myocardial Infarction (STEMI) (DISTEMI Study)
Lead sponsor
German Diabetes Center
Phase
Observational
Overall status
Recruiting
Start date
December 30, 2018
Completion date
December 30, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin resistance, non-alcoholic fatty liver disease, st-segment elevation myocardial infarction (stemi)